Erratum: Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process
Saved in:
| Main Author: | Frontiers Production Office |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2025.1611335/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process
by: Breanne Stewart, et al.
Published: (2025-02-01) -
Status of registration, re-registration, and accreditation of ethics committees with Central Drugs Standard Control Organization, Department of Health Research, and National Accreditation Board for Hospitals and Healthcare Providers – An evaluation of the extent of ethics oversight in the country
by: Ananya Rakshit, et al.
Published: (2025-07-01) -
A Swedish Perspective on Research Ethics Review
by: Hans Thulesius
Published: (2010-12-01) -
Gaps in the Ottawa Statement on the Ethical Design and Conduct of Cluster Randomized Trials: a citation analysis reveals a need for updated ethics guidelines
by: Cory E. Goldstein, et al.
Published: (2025-06-01) -
The Development and Implementation of a Quality Improvement Review Committee (QIRC): An Ethical and Pragmatic Imperative
by: Sarah E. McMillan, et al.
Published: (2024-12-01)